Neous Therapeutics Cash Flow - Annual (NASDAQ:NEOS)

Add to My Stocks
$4.9 $0.05 (1.01%) NEOS stock closing price Sep 19, 2018 (Closing)

The Neous Therapeutics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. Financials statements like the Neous Therapeutics income statement and Neous Therapeutics balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. This statement can tell if a company is running out of money while still being profitable and is useful in Neous Therapeutics stock analysis. Neous Therapeutics had a negative net income cash flow of $-66.24M for the latest 2017. This report is very useful in measuring the short term viability of a company. The cash from operating activities for Neous Therapeutics is $ 2017, which saw an increase from previous year.

View details of Neous Therapeutics cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
-66.24M-83.33M-30.78M-20.84M-19.03M
Depreciation Depletion Amortization Cash-Flow4.33M3.66M3.81M3.34M2.31M
Net Increase (Decrease) in Assets Liabilities3.23M--1.09M--
Cash From (used in) Discontinued Operations-----
Other Adjustments Net5.41M8.08M2.18M-0.07M1.24M
Net Cash from (used by) Operating Activities
-53.26M-70.64M-25.86M-17.39M-14.95M
Increase (Decrease) in Prop Plant And Equipment-2.49M-3.55M-1.02M-0.33M-2.01M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-2.89M-15.27M3M4.49M-7.49M
Other Cash Inflow (Outflow) from Investment Activities2.86M-0.5M--6.28M-
Net Cash from (used by) Investment Activities
-2.53M-19.32M1.97M-2.12M-9.51M
Issuance (Purchase) of Equity Shares64.43M-0.04M92.96M17.35M8.52M
Issuance (Repayment) of Debt Securities-0.98M23.19M8.34M3.32M-0.89M
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-0.04M---5.5M
Net Cash from (used by) Financing Activities
63.41M23.55M101.31M20.91M13.13M
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
7.61M-66.41M77.42M1.39M-11.33M
Cash & Equivalents at Beginning of Year24.35M90.76M13.34M11.94M23.28M
Cash & Equivalents at Year End31.96M24.35M90.76M13.34M11.94M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Neous Therapeutics stock price history and Neous Therapeutics stock comparison chart inevitably reflect its cash flow situation.

  • Neous Therapeutics saw a positive change in Net Change in Cash and Cash Equivalents of $7.61M in 2017. Apart from the Neous Therapeutics stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-53.26M for NEOS.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-2.53M for NEOS stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Neous Therapeutics earned $63.41M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Neous Therapeutics Cash Flow